User profiles for Natalie J. Thornburg
 | Natalie ThornburgCenters for Disease Control and Prevention Verified email at cdc.gov Cited by 27904 |
[HTML][HTML] Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
…, A Tamin, JL Harcourt, NJ Thornburg… - New England journal …, 2020 - Mass Medical Soc
Aerosol and Surface Stability of SARS-CoV-2 In this research letter, investigators report on
the stability of SARS-CoV-2 and SARS-CoV-1 under experimental conditions. The viability of …
the stability of SARS-CoV-2 and SARS-CoV-1 under experimental conditions. The viability of …
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
…, G Painter, J Harcourt, A Tamin, NJ Thornburg… - Science translational …, 2020 - science.org
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks,
most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of …
most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of …
[HTML][HTML] US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2
…, J Harcourt, A Tamin, NJ Thornburg… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic
agent associated with coronavirus disease, which emerged in late 2019. In response, we …
agent associated with coronavirus disease, which emerged in late 2019. In response, we …
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020
…, S Yendell, J Schiffer, NJ Thornburg - JAMA internal …, 2020 - jamanetwork.com
Importance Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection likely underestimate the prevalence of infection in affected communities. Large-…
infection likely underestimate the prevalence of infection in affected communities. Large-…
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States
…, S Tong, VD Menachery, NJ Thornburg - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe
acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States …
acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States …
[PDF][PDF] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
…, T Kyle, AV Gundlapalli, NJ Thornburg… - JAMA internal …, 2021 - jamanetwork.com
Importance Case-based surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection likely underestimates the true prevalence of infections. Large-scale …
infection likely underestimates the true prevalence of infections. Large-scale …
Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021
…, NJ Thornburg, S Kleinman, SL Stramer, J Opsomer… - Jama, 2021 - jamanetwork.com
Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo …
Background Microneedle patches provide an alternative to conventional needle-and-syringe
immunisation, and potentially offer improved immunogenicity, simplicity, cost-effectiveness, …
immunisation, and potentially offer improved immunogenicity, simplicity, cost-effectiveness, …
Household transmission of severe acute respiratory syndrome coronavirus-2 in the United States
…, L Pawloski, NJ Thornburg… - Clinical Infectious …, 2021 - academic.oup.com
Background The evidence base for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
is nascent. We sought to characterize SARS-CoV-2 transmission within US …
is nascent. We sought to characterize SARS-CoV-2 transmission within US …
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
…, CG Grijalva, CJ Lindsell, SN Lester, NJ Thornburg… - Bmj, 2022 - bmj.com
Objective To compare the effectiveness of a primary covid-19 vaccine series plus booster
doses with a primary series alone for the prevention of hospital admission with omicron related …
doses with a primary series alone for the prevention of hospital admission with omicron related …